This can be achieved through several strategies:
Prodrug Design: A prodrug is a chemical derivative of a drug that undergoes biotransformation in the body to release the active drug. Prodrugs are designed to enhance the drug's bioavailability by addressing specific challenges. For example, a prodrug may be more water-soluble than the parent drug, thereby improving absorption. Once in the body, enzymes cleave the prodrug to release the active drug.
Salt Formation: Salt formation involves combining a drug with an inorganic or organic acid or base to form a salt. This can improve drug solubility and dissolution rate, leading to enhanced bioavailability. For instance, the salt form of a drug may be more soluble in aqueous environments, such as the gastrointestinal tract, facilitating its absorption.
Complexation: Complexation involves forming a non-covalent complex between a drug and a complexing agent. Cyclodextrins, for example, are cyclic oligosaccharides that can form inclusion complexes with drug molecules. These complexes can improve drug solubility, dissolution rate, and stability, thereby enhancing bioavailability.
Micronization: Micronization is a process of reducing the particle size of a drug to the micron range. This increases the drug's surface area, resulting in faster dissolution and improved bioavailability. Micronized drugs disperse more uniformly in aqueous media, allowing for more efficient absorption.
Solid Dispersions: Solid dispersions involve dispersing a drug within a hydrophilic or hydrophobic carrier matrix in a solid state. This technique enhances drug solubility and dissolution rate by minimizing drug crystallinity and increasing the drug's surface area. Solid dispersions can be prepared using various methods, such as melt extrusion, hot-melt mixing, and spray drying.
Nanoparticle Formulations: Nanoparticles are drug delivery systems with particle sizes ranging from 1 to 100 nanometers. They can improve bioavailability by increasing drug solubility, protecting the drug from degradation, and enhancing drug targeting. Nanoparticles can be administered orally, intravenously, or through other routes of administration.
By making small chemical changes to drug molecules or employing formulation strategies, it is possible to improve their bioavailability and optimize their therapeutic effects. These approaches enable drugs to reach the systemic circulation more effectively, leading to improved drug efficacy and reduced side effects.
